Loading company…
Cambridge-based Ovation Life Sciences, LLC generates genomic and omics data linked to longitudinal clinical records for drug discovery.
Founded in 2009 in Cambridge, US, Ovation Life Sciences, LLC provides genomic and omics datasets linked to clinical data through the Ovation Research Network and Ovation LIMS, a laboratory information management system. Barry Wark is CEO, with Jason Painter and Winston Brasor in the founding team. In August 2024 the company merged with PD Theranostics, Inc., and its latest funding was a USD 21.50 mn Series B led by SignalFire, with Black Point Group, Borealis Ventures, Madrona Venture Group and StageDotO. It has completed eight deals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in